Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Hold | 16,600,508 | $56.80 | $943M | — | — | |
| CEIXEUR - Consol Energy | Add +4.7% | 2,845,681 | $67.81 | $193M | +128,940 | +$35M | |
| BHF - Brighthouse Finl | Hold | 3,122,743 | $47.35 | $148M | — | — | |
| Black Knight | Add +44.6% | 1,336,800 | $59.73 | $80M | +412,060 | +$27M | |
| THC - Tenet Healthcare | Reduce −34.7% | 932,070 | $81.38 | $76M | −494,900 | −$9M | |
| ODP1 - The Odp | Reduce −7.1% | 1,516,010 | $46.82 | $71M | −116,130 | −$2M | |
| CPRI - Capri | Add +32.3% | 1,646,136 | $35.89 | $59M | +402,096 | +$610K | |
| KD - Kyndryl | Reduce −47.7% | 4,448,766 | $13.28 | $59M | −4,050,079 | −$66M | |
| TECK - Teck Resources · CL B | Reduce −46.0% | 1,346,023 | $42.10 | $57M | −1,145,195 | −$34M | |
| Southwestern Energy | Add +3.5% | 9,226,650 | $6.01 | $55M | +310,950 | +$11M | |
| LIVN - Livanova | Hold | 1,034,896 | $51.43 | $53M | — | — | |
| PKG - Graphic Packaging | Add +65.6% | 1,767,680 | $24.03 | $42M | +700,010 | +$15M | |
| GLD - Spdr Gold Tr | Hold | 227,899 | $178.27 | $41M | — | — | |
| NPWR - Net Power · CL A | New | 2,510,000 | $13.00 | $33M | +2,510,000 | +$33M | |
| FCNCA - First Ctzns Bancshares · CL A | Hold | 22,550 | $1,283 | $29M | — | — | |
| WFRD - Weatherford Intl | Reduce −25.1% | 434,115 | $66.42 | $29M | −145,580 | −$6M | |
| SLV - Ishares Silver Tr | Reduce −16.9% | 1,236,630 | $20.89 | $26M | −250,750 | −$7M | |
| GPOR - Gulfport Energy | Reduce −24.0% | 215,190 | $105.07 | $23M | −67,810 | −$30K | |
| NYCBEUR - New York Cmnty Bancorp | Reduce −25.1% | 1,707,460 | $11.24 | $19M | −572,050 | −$1M | |
| Activision Blizzard | New | 221,880 | $84.30 | $19M | +221,880 | +$19M | |
| FHN - First Horizon | New | 1,298,780 | $11.27 | $15M | +1,298,780 | +$15M | |
| SDRL - Seadrill 2021 | New | 266,485 | $41.27 | $11M | +266,485 | +$11M | |
| GPRO - Gopro · CL A | Hold | 2,597,900 | $4.14 | $11M | — | — | |
| REZI - Resideo Technologies | Reduce −25.6% | 489,299 | $17.66 | $9M | −168,789 | −$3M | |
| LKFT - Galapagos | Reduce −0.8% | 150,168 | $40.66 | $6M | −1,200 | +$257K | |
| Danimer Scientific · CL A | Hold | 2,550,000 | $2.38 | $6M | — | — | |
| HRI - HERC | New | 37,160 | $136.85 | $5M | +37,160 | +$5M | |
| Waverley Capital Acquis | Hold | 350,000 | $10.40 | $4M | — | — | |
| AAP - Advance Auto Parts | New | 37,570 | $70.30 | $3M | +37,570 | +$3M | |
| GANX - Gain Therapeutics | Hold | 546,560 | $4.48 | $2M | — | — | |
| OIH - Vaneck ETF Trust | Hold | 6,960 | $287.60 | $2M | — | — | |
| COYA - Coya Therapeutics | Hold | 392,647 | $4.07 | $2M | — | — | |
| FCG - First Tr Exchange-Traded Fd | Hold | 58,540 | $23.28 | $1M | — | — | |
| IVZ - Invesco Actvely Mngd Etc Fd | Hold | 96,990 | $13.60 | $1M | — | — | |
| Talis Biomedical | Hold | 2,235,783 | $0.4800 | $1M | — | — | |
| OHRPEUR - Neubase Therapeutics | New | 136,350 | $1.87 | $255K | +136,350 | +$255K | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $1.80 | $63K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2023 Q1
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| GPN - Global Pmts | Exit | 0 | $105.24 | $63M | −600,430 | −$63M | |
| CIVI - Civitas Resources | Exit | 0 | $68.34 | $31M | −458,208 | −$31M | |
| CNXC - Concentrix | Exit | 0 | $121.55 | $25M | −207,961 | −$25M | |
| Rice Acquisition Ii · CL A | Exit | 0 | $10.24 | $8M | −760,000 | −$8M | |
| Panacea Acquisition Ii · CL A | Exit | 0 | $10.22 | $3M | −275,000 | −$3M | |
| Neubase Therapeutics | Exit | 0 | $0.1852 | $505K | −2,727,027 | −$505K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2